Clinical Trials Directory

Trials / Completed

CompletedNCT03790618

Effect of Stimulant Drugs on Social Perception

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
36 (actual)
Sponsor
University of Chicago · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The study will improve our understanding of the "prosocial" effects of ± 3,4-Methylenedioxymethamphetamine (MDMA), relative to a prototypical stimulant, methamphetamine (MA). The investigators seek to characterize the "uniquely social" effects of MDMA.

Conditions

Interventions

TypeNameDescription
DRUG3,4-MethylenedioxymethamphetamineParticipants will be given 0.75mg/kg of 1.5mg/kg MDMA
DRUGmethamphetaminePlease see above.

Timeline

Start date
2016-06-01
Primary completion
2018-08-01
Completion
2018-08-01
First posted
2018-12-31
Last updated
2024-01-05
Results posted
2024-01-05

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03790618. Inclusion in this directory is not an endorsement.

Effect of Stimulant Drugs on Social Perception (NCT03790618) · Clinical Trials Directory